The Role of Age and Sex in Non-linear Dilution Adjustment of Spot Urine Arsenic

Thomas Clemens Carmine
DOI: https://doi.org/10.1101/2023.04.12.23288341
2024-06-27
Abstract:Background Previous research introduced V-PFCRC as an effective spot urinary dilution adjustment method for various metal analytes, including the major environmental toxin arsenic. V-PFCRC normalizes analytes to 1 g/L creatinine (CRN) by adopting more advanced power-functional corrective equations accounting for variation in exposure level. This study expands on previous work by examining the impacts of age and sex on corrective functions. Methods Literature review of the effects of sex and age on urinary dilution and the excretion of CRN and arsenic. Data analysis included a Data Set 1 of 5,752 urine samples and a partly overlapping Data Set 2 of 1,154 combined EDTA blood and urine samples. Both sets were classified into age bands, and the means, medians, and interquartile ranges for CRN and TWuAs in uncorrected (UC), conventionally CRN-corrected (CCRC), simple power-functional (S-PFCRC), sex-aggregated (V-PFCRC SA), and sex-differentiated V-PFCRC SD modes were compared. Correlation analyses assessed residual relationships between CRN, TWuAs, and age. V-PFCRC functions were compared across three numerically similar age groups and both sexes. The efficacy of systemic dilution adjustment error compensation was evaluated through power-functional regression analysis of residual CRN and the association between arsenic in blood and all tested urinary result modes. Results Significant sex differences in UC and blood were neutralized by CCRC and reduced by V-PFCRC. Age showed a positive association with blood arsenic and TWuAs in all result modes, indicating factual increments in exposure. Sex-differentiated V-PFCRC best matched the sex-age kinetics of blood arsenic. V-PFCRC formulas varied by sex and age and appeared to reflect urinary osmolality sex-age-kinetics reported in previous research. V-PFCRC minimized residual biases of CRN on TWuAs across all age groups and sexes, demonstrating improved standardization efficacy compared to UC and CCRC arsenic. Interpretation Sex differences in UC and CCRC arsenic are primarily attributable to urinary dilution and are effectively compensated by V-PFCRC. While the sex and age influence on V-PFCRC formulas align with sex- and age-specific urinary osmolality and assumed baseline vasopressor activities, their impact on correction validity for entire collectives is minimal. Conclusion The V-PFCRC method offers a robust correction for urinary arsenic dilution, significantly reducing systemic dilution adjustment errors. Its application in various demographic contexts enhances the accuracy of urinary biomarker assessments, benefiting clinical and epidemiological research. V-PFCRC effectively compensates for sex differences in urinary arsenic. Age-related increases in TWuAs are exposure-related and should be additionally accounted for by algebraic normalization, covariate models, or standard range adjustments. Keywords: Non-linear dilution adjustment, spot urine, biomarkers, arsenic, sex-age differences, exposure studies.
Occupational and Environmental Health
What problem does this paper attempt to address?
This paper examines the role of age and gender in non-linear dilution-corrected urinary arsenic concentrations. The study focuses on how to adjust the concentration of arsenic in urine samples more accurately to reflect inter-individual differences, particularly considering the influences of age and gender. The authors propose a Variable Power Functional Creatinine Correction (V-PFCRC) method and investigate the effects of age and gender on arsenic levels in urine and blood through the analysis of a large number of urine samples. The research methodology involves the analysis of urine and blood samples from different age groups and genders to assess the limitations of traditional correction methods. A V-PFCRC formula tailored to age and gender differences is developed. By comparing the results under different correction models, the authors validate the effectiveness of V-PFCRC in reducing systematic dilution correction errors. The study also discusses how age and gender affect the excretion of arsenic in urine and blood, as well as related physiological and hormonal factors. The findings suggest that age and gender do indeed influence arsenic concentrations in urine, and the V-PFCRC method can better compensate for these differences, especially for males and females in different age groups. The study also highlights age-related changes in kidney function and how sex hormones affect urine concentration, arsenic excretion, and creatinine levels. In conclusion, this paper aims to address the issue of how to adjust urinary biomarkers more accurately when evaluating exposure to environmental toxins such as arsenic, in order to eliminate errors caused by age and gender differences and improve the accuracy of clinical and epidemiological research.